Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TJ 25

Drug Profile

TJ 25

Alternative Names: Gui-zhi-fu-ling-wan; Keishi-bukuryo-gan; Keishi-bukuryu-gan; Kuei-chih-fu-ling-wan; TJ25; TU-025; TU-25

Latest Information Update: 22 May 2007

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Tsumura
  • Class Herbal medicines; Phytotherapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Hot flashes

Most Recent Events

  • 22 May 2007 Discontinued - Phase-II for Hot flashes in USA (PO)
  • 12 Feb 2004 Launched for Hot flashes in Japan (PO)
  • 12 Feb 2004 Phase-II clinical trials in Hot flashes in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top